Dr Oludare Odumosu Archives | Cannabiz

Zelira share price rockets as study shows cannabinoid drug outperforms multibillion dollar Pfizer product

by Steve Jones June 1, 2023June 1, 2023

ASX-listed Zelira Therapeutics saw its share price soar 230% yesterday after revealing its cannabinoid medication for […]

Zelira

Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma

by Martin Lane and Steve Jones May 23, 2023May 23, 2023

Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics

by Martin Lane March 16, 2023March 16, 2023

Company news: Neurotech; Emyria; Cann Group; Incannex; Creso Pharma; Greenfern; Zelira; Organic Genetics

by Martin Lane November 24, 2022November 24, 2022

Zelira

Company news: Zelira Therapeutics; Hygrovest; Epsilon Healthcare

by Martin Lane September 22, 2022September 22, 2022

Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience

by Steve Jones and Martin Lane September 1, 2022September 1, 2022

Zelira

Zelira’s ‘multiple shots on goal’ will drive profitability, says global CEO

by Steve Jones June 30, 2022July 7, 2022

Zelira’s Health House acquisition called off

by Martin Lane and Steve Jones June 22, 2022June 23, 2022

Company news: Wellnex Life; Incannex; Tetra Bio-Pharma; Zelira

by Martin Lane June 8, 2022June 9, 2022

Company news: Helius; Greenfern Industries; Zelira; Creso Pharma; Emyria; Roto-Gro International

by Martin Lane June 2, 2022June 2, 2022